Bivalent rLP2086 (Trumenba®): Development of a well-characterized vaccine through commercialization
Titel:
Bivalent rLP2086 (Trumenba®): Development of a well-characterized vaccine through commercialization
Auteur:
Sunasara, Khurram Cundy, John Srinivasan, Sriram Evans, Brad Sun, Weiqiang Cook, Scott Bortell, Eric Farley, John Griffin, Daniel Bailey Piatchek, Michele Arch-Douglas, Katherine